VA St. Louis Health Care System — St Louis, Missouri

Public research footprint of VA St. Louis Health Care System, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Metastatic Castrate Resistant Prostate Cancer (mCRPC) · Castrate-sensitive Prostate Cancer · Carcinoma, Non-Small-Cell Lung · Metastatic Castration-Resistant Prostate Cancer

Recently updated registry entries

NCT05272176 — Veterans Coordinated Community Care (3C) Study (Completed)
NCT05422911 — Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. (Recruiting)
NCT05939414 — An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at VA St. Louis Health Care System?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.